Kristen Williams is CAO at Pacira BioSciences, Inc. (PCRX). They have made 1 open-market trade across 1 company since 2024, most recently 2026-06-04.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PCRX | 167,062 | $6.1M |
Shares reported on the most recent Form 4, priced at the 2026-06-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PCRX | SELL · 10b5-1 | 2026-06-04 | 2026-06-05 | $22.27 | $228K | -1.0% | +11.9% | +16.3% |
| PCRX | SELL · 10b5-1 | 2026-02-02 | 2026-02-03 | $20.53 | $270K | +3.0% | +8.1% | +16.8% |
| PCRX | SELL | 2025-06-04 | 2025-06-05 | $26.24 | $754K | -8.6% | -13.0% | +1.9% |
| PCRX | SELL · 10b5-1 | 2024-06-13 | 2024-06-13 | $28.38 | $423K | -1.0% | -23.7% | -53.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.